NO984093L - FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider - Google Patents

FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider

Info

Publication number
NO984093L
NO984093L NO984093A NO984093A NO984093L NO 984093 L NO984093 L NO 984093L NO 984093 A NO984093 A NO 984093A NO 984093 A NO984093 A NO 984093A NO 984093 L NO984093 L NO 984093L
Authority
NO
Norway
Prior art keywords
prosaposin
neuropathic pain
methods
derived peptides
relieving neuropathic
Prior art date
Application number
NO984093A
Other languages
English (en)
Norwegian (no)
Other versions
NO984093D0 (no
Inventor
John S O'brien
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO984093D0 publication Critical patent/NO984093D0/no
Publication of NO984093L publication Critical patent/NO984093L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO984093A 1996-03-05 1998-09-04 FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider NO984093L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/611,307 US6271196B1 (en) 1996-03-05 1996-03-05 Methods of alleviating neuropathic pain using prosaposin-derived peptides
PCT/US1997/004143 WO1997032895A1 (fr) 1996-03-05 1997-03-05 Methodes de soulagement de la douleur nevropathique a l'aide de peptides derives de prosaposine

Publications (2)

Publication Number Publication Date
NO984093D0 NO984093D0 (no) 1998-09-04
NO984093L true NO984093L (no) 1998-11-04

Family

ID=24448513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984093A NO984093L (no) 1996-03-05 1998-09-04 FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposinavledede peptider

Country Status (16)

Country Link
US (2) US6271196B1 (fr)
EP (1) EP0929569B1 (fr)
JP (1) JP4138006B2 (fr)
KR (1) KR100507715B1 (fr)
AT (1) ATE340187T1 (fr)
AU (1) AU734566B2 (fr)
CA (1) CA2248139C (fr)
CZ (1) CZ297384B6 (fr)
DE (1) DE69736712T2 (fr)
IL (1) IL126082A0 (fr)
NO (1) NO984093L (fr)
NZ (1) NZ331757A (fr)
PL (1) PL187917B1 (fr)
RU (2) RU2223969C2 (fr)
SK (1) SK122898A3 (fr)
WO (1) WO1997032895A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US6849602B1 (en) * 1996-03-05 2005-02-01 The Regents Of The University Of California Compositions for alleviating neuropathic pain with prosaposin receptor agonists
EP0979238A4 (fr) * 1997-03-05 2000-08-23 Univ California Procedes pour soulager les douleurs neuropathiques
AU4267297A (en) * 1997-09-11 1998-09-22 Regents Of The University Of California, The Method of alleviating neuropathic pain
AU7795698A (en) * 1997-03-24 1998-10-20 Myelos Corporation Synthetic saposin c-derived neurotrophic peptides
JP2001515866A (ja) * 1997-09-09 2001-09-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロサポシン受容体アゴニストを利用したアポトーシスの阻害
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides
IL141586A0 (en) * 1998-08-28 2002-03-10 Myelos Corp Cyclic prosaposin-derived peptide and uses thereof
US20020028783A1 (en) * 1999-09-09 2002-03-07 O'brien John S. Method of stimulating prosaposin receptor activity
USRE45976E1 (en) * 1999-02-24 2016-04-19 Tact Ip, Llc Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally
CA2367766A1 (fr) * 1999-03-30 2000-10-05 Myelos Corporation Peptides retro-inverso derives de la prosaposine et leur utilisation
US7309687B1 (en) 1999-04-13 2007-12-18 The Kenneth S. Warren Institute, Inc. Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
US7345019B1 (en) 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
US7135461B1 (en) 2000-06-16 2006-11-14 Myelos Corporation Retro-inverso peptides derived from interleukin-6
IL147094A0 (en) * 1999-06-16 2002-08-14 Myelos Corp Retro-inverso peptides derived from interleukin-6
US7109168B1 (en) 2000-06-16 2006-09-19 Myelos Corporation Retro-inverso peptides derived from leukemia inhibitory factor
AU5622700A (en) * 1999-06-16 2001-01-02 Myelos Corporation Retro-inverso peptides derived from leukemia inhibitory factor
IL147093A0 (en) * 1999-06-16 2002-08-14 Myelos Corp Retro-inverso peptides derived from interleukin-3
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US20050074747A1 (en) * 2000-09-08 2005-04-07 Wadih Arap Biopanning and rapid analysis of selective interactive ligands (brasil)
US6531121B2 (en) 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
US20060287240A1 (en) * 2001-03-09 2006-12-21 O'brien John S Method of stimulating prosaposin receptor activity
US20040176290A1 (en) * 2001-07-18 2004-09-09 Renata Pasqualini Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US20040096089A1 (en) * 2002-08-16 2004-05-20 David Borsook Non-invasive functional imaging of peripheral nervous system activation in humans and animals
US7166691B2 (en) * 2002-12-20 2007-01-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Saposin C and receptors as targets for treatment of benign and malignant disorders
DK1605965T3 (da) * 2003-03-26 2013-04-15 Evotec Internat Gmbh Anvendelse af saposin-beslægtede proteiner til forebyggelse og behandling af obesitet, diabetes og/eller metabolisk syndrom
BRPI0409523A (pt) * 2003-03-28 2006-04-18 Acadia Pharm Inc método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
US7834147B2 (en) * 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
US9345745B2 (en) * 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
US7964585B2 (en) * 2006-03-14 2011-06-21 Case Western Reserve University Composition and method of treating peripheral neuropathy
KR20180041269A (ko) 2008-01-22 2018-04-23 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
RU2561582C2 (ru) * 2010-11-19 2015-08-27 Российская Федерация в лице Министерства промышленности и торговли Российской Федерации Инъекционная лекарственная форма олигопептидного препарата для лечения рассеянного склероза и способ ее получения
JP5971729B2 (ja) * 2011-02-23 2016-08-17 北海道公立大学法人 札幌医科大学 疼痛を治療、改善、または予防するための組成物
RU2669692C1 (ru) * 2017-08-14 2018-10-15 Павел Андреевич Канаев Способ получения комплекса биологически активных пептидов обладающих нейротропной активностью
KR102370952B1 (ko) 2018-03-23 2022-03-07 벡션 파마슈티컬스 인크. 사포신 c 약학 조성물 및 암 치료 방법
RU2020131598A (ru) 2018-03-29 2022-04-29 Лэйтерал Ип Пти Лтд Циклические пептиды и их применение

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108459T1 (de) 1986-04-22 1994-07-15 Salk Inst For Biological Studi Antagonisten des fibroblasten-wachstumsfaktors.
WO1993015722A1 (fr) 1992-02-07 1993-08-19 Syntex (Usa) Inc. Liberation controlee de produits pharmaceutiques a partir de microparticules poreuses preformees
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
EP0979238A4 (fr) * 1997-03-05 2000-08-23 Univ California Procedes pour soulager les douleurs neuropathiques
AU7795698A (en) * 1997-03-24 1998-10-20 Myelos Corporation Synthetic saposin c-derived neurotrophic peptides

Also Published As

Publication number Publication date
US6268347B1 (en) 2001-07-31
IL126082A0 (en) 1999-05-09
JP4138006B2 (ja) 2008-08-20
PL328701A1 (en) 1999-02-15
NO984093D0 (no) 1998-09-04
CZ297384B6 (cs) 2006-11-15
EP0929569B1 (fr) 2006-09-20
US6271196B1 (en) 2001-08-07
CA2248139A1 (fr) 1997-09-12
CA2248139C (fr) 2004-05-18
RU2223969C2 (ru) 2004-02-20
KR100507715B1 (ko) 2006-05-26
ATE340187T1 (de) 2006-10-15
NZ331757A (en) 1999-10-28
DE69736712D1 (de) 2006-11-02
RU2003131695A (ru) 2005-04-10
EP0929569A1 (fr) 1999-07-21
CZ283998A3 (cs) 1999-05-12
KR19990087686A (ko) 1999-12-27
WO1997032895A1 (fr) 1997-09-12
EP0929569A4 (fr) 2000-08-23
RU2266129C2 (ru) 2005-12-20
JP2000506853A (ja) 2000-06-06
AU734566B2 (en) 2001-06-14
AU2328697A (en) 1997-09-22
PL187917B1 (pl) 2004-11-30
SK122898A3 (en) 2000-02-14
DE69736712T2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
NO984093D0 (no) FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptider
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
EP0831832A4 (fr) Procedes pour lutter contre des maladies infectieuses a l'aide de bis-benzimidazoles dicationiques
DK0867178T3 (da) Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser
AU9021298A (en) Agmatine as a treatment for neuropathic pain
EP0813544A4 (fr)
EA199800866A1 (ru) Способ снятия боли
EP1049479A4 (fr) Analgesique obtenu a partir de venin de serpent
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
WO1999065475A3 (fr) Combinaison de phentolamine et apomorphine pour le traitement concernant les fonctions et les dysfonctionnements sexuels
NO982582L (no) Fremgangsmaate for behandling av smerte
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
AU5434899A (en) Cancer treatment
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
EP1007050A4 (fr) Methode de traitement de la pharmacodependance
NO984190L (no) FremgangsmÕte for behandling av insomnia
AU4390597A (en) Combination therapy for treatment of arthritic diseases
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA32108A (uk) Спосіб лікування хронічного тонзиліту
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
UA8280A (uk) Спосіб лікування псоріазу

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application